Pfizer's business may be in better shape than investors think.
A symbol of American pharmaceutical innovation for nearly two centuries, Pfizer now faces the challenges of AI adoption and the promise of smarter medicines. Pfizer CEO Albert Bourla discussed ...
Many of us can easily pinpoint the artificial intelligence (AI) investments in our portfolios. Maybe you've bought shares of AI company stocks or invested in ETFs focused on AI, technology, or ...
If it weren't for question marks about its future growth, Pfizer (NYSE: PFE) stock would undoubtedly be trading at a much higher price. Sales were down last year, and the stock has been floundering, ...
Albert Bourla, Pfizer's chief executiveFabrice Coffrini/AFP/Getty Images Pfizer Chief Executive Albert Bourla is battling impending expirations for some blockbuster-drug patents and the precipitous ...
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...